Hampshire & Isle of Wight Medicines Safety Group Update

Written by ArturPysz on Friday 10th July 2026

Points relevant to Community Pharmacy from the last meeting

Points relevant to Community Pharmacy

  1. High-dose opioid patients
    • The safety group highlighted a system wide gap in identifying and managing patients on high-dose chronic opioids.
    • Community pharmacy input was specifically noted as important to support identification/management, however this activity is not currently funded.
  2. Steroid emergency card guidance
    • A patient safety incident has prompted discussion about clearer guidance on steroid card deployment.
    • Pharmacies should ensure all relevant patients are given a steroid card and advice.
  3. Propranolol for anxiety / overdose risk
    • There is ongoing national concern around propranolol use for anxiety, especially in younger patients or those with mental health histories.
    • Pharmacies: Please be aware of risk of overdose, any requests for urgent supplies, counselling, and signposting where clinically appropriate.
  4. Lithium monitoring and communication gaps
    • A lithium toxicity case highlighted gaps in monitoring and communication between primary and secondary care.
    • Pharmacies: Remain alert to lithium toxicity symptoms, renal function concerns, and escalation routes.
  5. Insulin safety
    • Risks around withdrawing insulin from cartridges were discussed, mainly in relation to nursing practice, but the safety message is relevant across sectors.
    • Pharmacies: Ensure patients are using a reusable pen and are getting a prescription item for needles with their cartridges.
  6. Yellow Card reporting
    • The safety group discussed encouraging Yellow Card reporting, including system-related medication safety concerns.
    • Pharmacies: Remember to use the Yellow Card reporting for any adverse events reported.